Results 71 to 80 of about 7,735 (212)
Background Multi-drug or rifamycin-resistant tuberculosis (MDR/RR-TB) is an important public health concern, including in settings with high HIV prevalence.
Nesbert Zinyakatira +2 more
doaj +1 more source
Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
BACKGROUND Rifamycins are a group of antibiotics mainly used in the treatment of tuberculosis (TB), however they interact with antiretroviral therapy (ART).
Carolina Arana Stanis Schmaltz +3 more
doaj +1 more source
Clostridioides difficile infections are increasingly problematic in areas with already burdened healthcare systems. From a One‐Health perspective, a lack of surveillance in developing countries greatly contributes to the limited information available on the zoonotic and foodborne potential of C. difficile.
M. Gouws, P. E. Strydom, D. Rip
wiley +1 more source
Cefdinir reprograms Gram‐positive bacteria to synergize with lysozyme against superbugs
Abstract Multidrug‐resistant (MDR) bacteria pose a critical global health threat, urgently requiring solutions. Cefdinir, the highest‐selling third‐generation cephalosporin but one now facing clinical obsolescence due to escalating resistance, is conventionally classified as a nascent cell wall synthesis inhibitor.
Qi Zhang +6 more
wiley +1 more source
Systemic Absorption of Rifamycin SV MMX Administered as Modified-Release Tablets in Healthy Volunteers [PDF]
The new oral 200-mg rifamycin SV MMX modified-release tablets, designed to deliver rifamycin SV directly into the colonic lumen, offer considerable advantages over the existing immediate-release antidiarrheic formulations. In two pharmacokinetics studies
L. Loprete +5 more
core +1 more source
Diene Substitution Patterns in the Conformation‐Activity Relationships of GEX1A
Synthetic analogues of GEX1A were designed and synthesised in an effort to explore the significance of diene substitution on the conformational preferences and expand our understanding of the three‐dimensional pharmacophore for this biologically active natural product.
Christian A. Umaña +5 more
wiley +1 more source
Postmastectomy life-threatening hypersensitivity reactions induced by rifamycin sv in companion animals: Evaluation of 7 cases [PDF]
Drug-induced hypersensitivity and adverse symptoms related to the high mortality remain as a major problem for veterinary practitioners. Although application of Rifamycin SV without intradermal susceptibility tests have been commonly used in wound ...
Hatice Esra Çolakoğlu +7 more
core +1 more source
Preparation of McAbs against rifamycin and development of A competitive ELISA method [PDF]
Objective: To prepare the monoclonal antobodies (McAbs) against rifamycin and develop a competive ELISA method. Methods: Rifamycin was coupled to bovine serum albumin (BSA) and ovalbumin (OVA) as carriers respectively.
Zhang, Yun Tao, Xie, Yong, Cao, Xin Yun
core +1 more source
In 2021, the World Health Organization (WHO) recommended scaling up leprosy prevention activities, including chemoprophylaxis, as one of the pillars of their ‘Towards Zero Leprosy’ strategy.
Patrick O. Campbell +2 more
doaj +1 more source
Report concerning the colaborative study for establish of reference standard eficacity of Rifamycin [PDF]
The Microbiology Laboratory from the Institute for the Control of Veterinary Biological Products and Medicines participated in a collaborative study in order to determine the potency of rifamycin CRS, batch 4, according to the protocol sent by the EDQM ...
Simona Sturzu +5 more
doaj

